ForePass endoscopic bypass device for obesity and insulin resistance—metabolic treatment in a swine model

Faecal metabolome and its determinants in inflammatory bowel disease

Over-40s on antibiotics ‘nearly 50 per cent more likely to develop Crohn’s disease’

Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19 and may permanently alter the gut biome

Diet quality and risk and severity of COVID-19: a prospective cohort study - A diet characterised by healthy plant-based foods was associated with lower risk and severity of COVID-19

Study finds, that children with autism have a distinct and underdeveloped gut microbiome which is not associated with their diet (July 2021)

Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial (Oct 2020, n=20) Three autologous or allogenic (healthy donor) FMTs over a period of 4 months…

Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model (Aug 2019) "results indicate that microbiota-mediated intestinal and systemic immune aberrations contribute to the pathogenesis of AD"

The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS

Researchers found bacterial extracellular vesicles in human plasma. Exciting finding and promising research field.

Treatment with camu camu (Myrciaria dubia) prevents obesity by altering the gut microbiota and increasing energy expenditure in diet-induced obese mice

Study finds long-term use of proton-pump inhibitors is associated with an increased risk of gastric cancer

For the first time, the structure of the hepatitis C virus has been directly observed by electron microscopy and confirms the predicted ultrastructure of the virus

Intestinal cell damage and systemic immune activation in individuals reporting sensitivity to wheat in the absence of coeliac disease

Detection of precancerous gastric lesions and gastric cancer through exhaled breath

Microbiota-induced obesity requires farnesoid X receptor. Altered gut microbiota contributes to the obese phenotype.